reference/8491538

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8491538

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	2479
issn	1527-7755 0732-183X
issueIdentifier	10
pageRange	2472-2479
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	2472
bibliographicCitation	Gisselbrecht C, Lepage E, Molina T, Quesnel B, Fillet G, Lederlin P, Coiffier B, Tilly H, Gabarre J, Guilmin F, Hermine O, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte. Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma. J Clin Oncol. 2002 May 15;20(10):2472–9. doi: 10.1200/jco.2002.02.125. PMID: 12011124.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_909f2f89c7a40b25b9bbfff8d2632bf1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6563-2709 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81ce6a161825ab248d081025021c5bf3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_780d54de5dbf7b7215ba85f0dedc85e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5474791e8ff72d6903fe36c02b3c279b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e63092ae283146ce7f6f9d6a5af3179d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4c12269c8ff0cfa0c7d78db978ba84f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb2cab273053cb02002943233077132a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2574-3874 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3dc4af695b3d4e4aa8729c5e8d6b0d1f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a918f7e07f17d2b1c42e9f20803982a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7d08d4570ed65d5903453aec588275d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44a4dc2a24902ec0b51adaed25b5901b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1f83b06d3c374c2313369dac3cb19fa
date	2002-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2002.02.125 https://pubmed.ncbi.nlm.nih.gov/12011124
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma
discusses	http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0022680 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0002657
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018380 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D008223Q000628
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D001773Q000378 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D014182 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008223Q000473 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008223Q000401 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D001761Q000008 http://id.nlm.nih.gov/mesh/D001773Q000473 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D014751Q000008 http://id.nlm.nih.gov/mesh/D012074
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456190 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155903698 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360373 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40839 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460769 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2578 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84068 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129367670 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090536 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127750960 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135935854

Total number of triples: 84.